ArticleTherapeutic advances in medical oncology2020

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.

Alexandra Canonici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.